3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
64
Phase NA
22
Phase 1/2
19
Phase 2
18
Phase EARLY_PHASE1
4
Phase 2/3
3
Phase 4
2
Phase 3
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
174
Other
8
CNS
6
Breast
6
Thoracic
4
Gynecologic
4
Gastrointestinal
3
Genitourinary
2
Endocrine
2
Dermatologic
2
Other neoplasm
1
Classical hematology
1
Conditions
Melanoma
158
Keratosis, Actinic
75
Lymphoma, T-Cell, Cutaneous
36
Skin Neoplasms
27
Mycosis Fungoides
27
Lymphoma, Non-Hodgkin
25
Lymphoma, Mantle-Cell
25
Lymphoma, Large-Cell, Immunoblastic
25
Lymphoma, Large B-Cell, Diffuse
25
Lymphoma, Follicular
25
Leukemia, Lymphocytic, Chronic, B-Cell
25
Hodgkin Disease
25
Sezary Syndrome
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, B-Cell, Marginal Zone
24
Burkitt Lymphoma
24
Neoplasms
22
Carcinoma, Basal Cell
22
Neoplasm Metastasis
20
Multiple Myeloma
20
Leukemia, Myeloid, Chronic-Phase
20
Leukemia, Myeloid, Accelerated Phase
20
Leukemia, Hairy Cell
20
Leukemia, Myeloid, Acute
19
Blast Crisis
19
Primary Myelofibrosis
18
Lymphoma
18
Uveal Melanoma
17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, Large-Cell, Anaplastic
17
Interventions
nanocis
1
Technetium-99
1
Infracyanine green
1
Indocyanine Green
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Head and Neck Neoplasms
×
Dermatologic
×
Clear all
NCT05078047
2025-06-05
MOIO
UNICANCER
Phase 3
Recruiting
646 enrolled
NCT02997553
2023-01-09
GASVERT
Institut de Cancérologie de Lorraine
Phase 3
Completed
744 enrolled